Continuing Education
An Optimized Protocol for Detection of Coronary Artery Disease Using Technetium-99m-Sestamibi
Lynne Roy, Kenneth Van Train, James Bietendorf, Ernest Garcia, Russel Folks, Hosen Kiat, Jamshid Maddahi and Daniel S. Berman
Journal of Nuclear Medicine Technology June 1991, 19 (2) 63-67;
Lynne Roy
Cedars-Sinai Medical Center, Los Angeles, California and Emory University Hospital, Atlanta, Georgia
Kenneth Van Train
Cedars-Sinai Medical Center, Los Angeles, California and Emory University Hospital, Atlanta, Georgia
James Bietendorf
Cedars-Sinai Medical Center, Los Angeles, California and Emory University Hospital, Atlanta, Georgia
Ernest Garcia
Cedars-Sinai Medical Center, Los Angeles, California and Emory University Hospital, Atlanta, Georgia
Russel Folks
Cedars-Sinai Medical Center, Los Angeles, California and Emory University Hospital, Atlanta, Georgia
Hosen Kiat
Cedars-Sinai Medical Center, Los Angeles, California and Emory University Hospital, Atlanta, Georgia
Jamshid Maddahi
Cedars-Sinai Medical Center, Los Angeles, California and Emory University Hospital, Atlanta, Georgia
Daniel S. Berman
Cedars-Sinai Medical Center, Los Angeles, California and Emory University Hospital, Atlanta, Georgia

Abstract
This is the second article in the four-part series on “New Radiopharmaceuticals.” Upon completion of this article the reader should be able to: (1) identify imaging characteristics of technetium-99m-sestamibi and (2) understand the reconstruction and processing protocol.
In this issue
Journal of Nuclear Medicine Technology
Vol. 19, Issue 2
June 1, 1991
An Optimized Protocol for Detection of Coronary Artery Disease Using Technetium-99m-Sestamibi
Lynne Roy, Kenneth Van Train, James Bietendorf, Ernest Garcia, Russel Folks, Hosen Kiat, Jamshid Maddahi, Daniel S. Berman
Journal of Nuclear Medicine Technology Jun 1991, 19 (2) 63-67;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.